(INDIANAPOLIS) - Todd Rokita has announced his 11th opioid settlement as Indiana's Attorney General.

The settlement has secured approximately $720 million nationwide in settlements with eight drug makers that manufactured opioid pills. Indiana expects to receive approximately $16.5 million.

Rokita says thousands of Hoosiers have lost their lives as a result of the opioid crisis. Rokita says while the public can never undo the tragic loss of life, we can hold accountable those responsible for contributing to the situations culminating in these deaths. He says that’s what these settlements are all about, and he’s proud of the work of his team.

The eight defendants are Alvogen; Amneal; Apotex; Hikma; Indivior; Mylan (now part of Viatris); Sun; and Zydus.

The terms of the settlements vary. Some of the companies will remit payments to states annually over the course of years while others will pay their obligation in a single year.

Each of the settlements includes injunctive relief terms, namely: The companies are prohibited from engaging in the promotion of opioid products; They cannot provide financial rewards or impose discipline on employees based on the volume of opioids sold; They cannot manufacture, promote or distribute any product containing more that 40 mg of oxycodone per pill and also cannot in most circumstances offer discounts, coupons or rebates for opioid products; Finally they cannot provide funding or grants to third parties for the promotion of opioid products and cannot engage in any lobbying activity related to opioids.

The settlement brings Indiana to approximately $1.1 billion in total value of opioid settlements achieved since Rokita took office in January 2021.